• Chemotherapy emerges as the dominant cancer therapy, progressing from early agent development to combination regimens and adjuncts (hyperthermia) across solid tumors and leukemia [5], [6], [7], [8], [9], [17], [18], [19].

• Carcinogenesis research highlights initiation, mutational theory, and animal models shaping understanding of tumor onset and progression [4], [15], [16].

• Prognosis and pathology-based decision making link tissue/cell type and morphology to patient outcomes, guiding treatment strategy [1], [3], [11], [12].

• Natural behavior, metastasis, and circulating tumor cells reveal cancer's dissemination patterns and real-world biology [10], [13], [20].

• Clinical outcome reporting and survival metrics demonstrate progress in melanoma and broader cancer care, informing benchmarks [1], [2], [10].